NEWS

Nov 16, 2020  |

Nov 2, 2020  | 

Seal Rock Therapeutics Advancing Differentiated ASK1 Inhibitor Lead Candidate SRT-015 in NASH

Nov 9, 2018  |

Seal Rock Therapeutics - 500 Yale Ave N, Seattle, WA 98109, USA - info@sealrocktx.com -786.453.0593